We have studied the serology of 6 patients with palindromic rheumatism. 
Introduction

Palindromic rheumatism is characterized by recurrent attacks of acute arthritis of short duration. In the long term, some of these patients develop a connective tissue disease, usually rheumatoid arthritis (RA) (1, 2). Previous studies in Europe and North America showed that the presence of IgM rheumatoid factor (IgM-RF) in palindromic rheumatism patients indicates a future risk for RA
, and anti-cyclic citrullinated peptide antibody (anti-CCP Ab) was recently reported in palindromic rheumatism patients (5) . Thus, we measured IgM-RF and anti-CCP Ab in the sera of Japanese palindromic rheumatism patients.
Case Presentation
We encountered 6 patients with palindromic rheumatism, as diagnosed by the criteria described by Gonzalez-Lopez et al (1) . Informed consent was obtained from all of the patients. 
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Discussion
Gonzalez-Lopez et al have reported that 28% of patients with palindromic rheumatism developed RA after a mean follow-up of 6 years (1). Previous investigations including that of Gonzalez-Lopez et al showed that seropositivity for
IgM-RF could be one of the risk factors for subsequent development of RA (1) (2) (3) (4) 
